Title
Category
Credits
Event date
Cost
  • Movement Disorders
  • Neurology
  • Parkinson Disease
  • Side Effects
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
After several years, patients with Parkinson disease often experience OFF episodes, or periods each day when medication efficacy “wears off.” How can you increase their ON time? In this CME activity, follow along as 2 experts review evidence on treatment.
  • Antipsychotics
  • Functional Impairment
  • Movement Disorders
  • Neurology
  • Side Effects
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Two medications are FDA-approved to treat tardive dyskinesia, and new long-term evidence has been reported. Learn more from Dr. Joseph McEvoy.
  • Dementia
  • Diagnostic Tools
  • Geriatric Psychiatry
  • Neurology
  • Neuropsychiatric Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$10.00
InstructionsClick the red REGISTER button to pay the $10 fee and take the posttest. Click here to return to the JCP CME article
  • Movement Disorders
  • Neurology
  • Parkinson Disease
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Which medications can improve the motor and nonmotor symptoms of Parkinson disease? Dr Isaacson offers strategies to address multiple challenges.
  • Diagnostic Tools
  • Movement Disorders
  • Neurology
  • Parkinson Disease
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
What are the cardinal features of Parkinson disease? What other motor and nonmotor symptoms do patients experience? Review diagnosis and assessment tools.
  • Antipsychotics
  • Movement Disorders
  • Neurology
  • Patient/Physician Communication
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Do you know how to talk with your patients about the risk for tardive dyskinesia? Follow along as Dr Nierenberg offers tips for clear communication.
  • Delivery of Care
  • Movement Disorders
  • Neurology
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Measurement-based care has been found to be effective in patients with psychiatric conditions. Learn how to employ MBC for patients with tardive dyskinesia.
  • Delivery of Care
  • Diagnostic Tools
  • Geriatric Psychiatry
  • Neurology
  • Psychotic Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
What diagnostic criteria and assessment tools would you use for dementia-related psychosis? What strategies may help when discussing psychosis with patients’ family members? Dr Ballard considers these topics in this brief CME activity.
  • Alzheimer Disease
  • Antipsychotics
  • Dementia
  • Geriatric Psychiatry
  • Neurology
  • Parkinson Disease
  • Psychotic Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Antipsychotics can be used in the short-term to manage dementia-related psychosis, but serious adverse effects can outweigh benefits. Novel antipsychotics or other agents may offer superior efficacy and safety. Explore the evidence in this CME activity.